Conjugation of a biomolecule may be required for a variety of purposes, such as half-life extension, boost of the immune system or delivery of drugs to their target. If you plan to develop a conjugation of your biologic, we can support you in this endeavor. Thus, we offer a feasibility study to demonstrate the proof-of-concept of a bioconjugation approach. Feasibility studies typically take 1 to 3 months and support our customer to make a rapid decision for the best-for-purpose conjugation strategy.

Scope of work:
- Investigation of conjugation strategies
- Screening of different reagents, i.e. different PEGs
- Preparation of conjugate drug test samples
- Conjugate drugs for in vitro or in vivo testing and characterization at client site
Contact partner

Dr. Julia Wittmann
Head of Bioconjugation
+49 30 9489 2350